ARN2508

inhibits fatty acid amide hydrolase, Cox-1, and Cox-2; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Albani, Clara: 1 article (06/2015)
2.	Armirotti, Andrea: 1 article (06/2015)
3.	Habrant, Damien: 1 article (06/2015)
4.	Migliore, Marco: 1 article (06/2015)
5.	Moreno-Sanz, Guillermo: 1 article (06/2015)
6.	Piomelli, Daniele: 1 article (06/2015)
7.	Sasso, Oscar: 1 article (06/2015)
8.	Scarpelli, Rita: 1 article (06/2015)
9.	Summa, Maria: 1 article (06/2015)

1.	Inflammation (Inflammations) 06/01/2015 - "After oral administration in mice, ARN2508 engages its intended targets and exerts profound therapeutic effects in models of intestinal inflammation. "

1.	Therapeutic Uses

1.	Oral Administration